These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6430264)

  • 1. Value of maternal anti-D concentration in predicting the outcome of Rh(D) haemolytic disease.
    Harrison KL; Baker JW; Popper EI; Harden PA
    Aust N Z J Obstet Gynaecol; 1984 Feb; 24(1):6-8. PubMed ID: 6430264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
    Bowell P; Wainscoat JS; Peto TE; Gunson HH
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of maternal anti-D concentrations during pregnancy.
    Filbey D; Berseus O; Sandström B; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody protein levels in the maternal serum in rhesus iso-immunization.
    Fraser ID; Tovey GH; Lockyer WJ; Sobey DF
    J Obstet Gynaecol Br Commonw; 1972 Dec; 79(12):1074-9. PubMed ID: 4630429
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of discriminant analysis in relating maternal anti-D levels to the severity of haemolytic disease of the Newborn.
    Morley G; Gibson M; Eltringham D
    Vox Sang; 1977; 32(2):90-8. PubMed ID: 403679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative measurement of anti-D during pregnancy using a low ionic strength autoanalyser system.
    Douglas R; Staveley JM
    N Z Med J; 1972 Sep; 76(484):184-6. PubMed ID: 4629348
    [No Abstract]   [Full Text] [Related]  

  • 7. A management programme for Rh alloimmunization during pregnancy.
    Filbey D; Berseus O; Lindeberg S; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):11-20. PubMed ID: 3102210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of anti-Rh antibodies in amniotic fluid].
    Benoit P; Gagnon M; Doray BH; Bonin A; Bertrand R
    Union Med Can; 1972 Jan; 101(1):58-64. PubMed ID: 4622396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
    Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
    Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
    Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
    Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of anti-c in haemolytic disease of the newborn.
    Kozlowski CL; Lee D; Shwe KH; Love EM
    Transfus Med; 1995 Mar; 5(1):37-42. PubMed ID: 7767396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between maternal anti-D levels, fetal phenotype and haemolytic disease of the newborn.
    Morley G
    Vox Sang; 1978; 35(5):324-31. PubMed ID: 99877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of antibody protein in amniotic fluid to predict severity in rhesus haemolytic disease.
    Fraser ID; Tovey GH
    J Obstet Gynaecol Br Commonw; 1972 Nov; 79(11):981-4. PubMed ID: 4629885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Supervision of pregnant women isoimmunized with the rhesus factor. Significance and interpretation of the position of optic indices on the Liley diagram (425 cases)].
    Blanchard A; Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):107-31. PubMed ID: 4626034
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-D concentration in mother and child in haemolytic disease of the newborn.
    Hughes-Jones NC; Ivona M; Ellis J; Walker W
    Vox Sang; 1971 Aug; 21(2):135-40. PubMed ID: 5000958
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensive plasma exchange in the management of severe Rh disease.
    Angela E; Robinson E; Tovey LA
    Br J Haematol; 1980 Aug; 45(4):621-31. PubMed ID: 6775674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhesus haemolytic disease.
    Whittle MJ
    Arch Dis Child; 1992 Jan; 67(1 Spec No):65-8. PubMed ID: 1536591
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-U and haemolytic disease of the fetus and newborn.
    Smith G; Knott P; Rissik J; de la Fuente J; Win N
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1318-21. PubMed ID: 9883926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.